In this study, we observed that MMP-2 and MMP-9 secretion was increased with estrogen treatment of ER+ thyroid cancer cells, which was suppressed by treatment with DIM, providing not only a correlative link but a direct validation of the anti-estrogenic activity of DIM that alters thyroid cancer cell phenotype. This evidence concerns the gene ESR1 and thyroid gland carcinoma.